Allergy/Asthma News

BOSTON — Physicians suspect the solvent used in the administration of pembrolizumab may have triggered recurrent angioedema for a patient with squamous cell carcinoma, according to a poster presented at the CHEST Annual Meeting.

BOSTON — Combined treatments were associated with reduced asthma exacerbations compared with short-acting beta agonists alone, based on a review presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Patients with hereditary angioedema who used deucrictibant for 12 weeks experienced improved symptom control, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Healio has compiled October’s most read news in asthma and allergy.

As a physician, your career will be rewarding in many ways, including a personal sense of purpose, ability to help others and the potential for high-earning power.

Following the discontinuation of Flovent in January, ICU admissions, inpatient admissions and ED visits related to asthma rose in comparison with previous years, according to study results from Epic Research.

Pregnant women with mild asthma experienced few extrapulmonary treatable traits, according to research presented at the European Respiratory Society International Congress.

Several shifts in temperatures and weather patterns broke new records in 2023, threatening the health, nutrition and livelihood of people across the globe, a new report revealed.

BOSTON — Patients with mild asthma lowered their severe exacerbation risk by almost half by using as-needed albuterol-budesonide, according to data presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Patients with COPD, asthma and cystic fibrosis may soon be able to monitor their diseases by using/breathing through a tool that connects to their smartphone, according to a University of Pittsburgh press release.